Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03933436 · ClinicalTrials.gov registry record · NA

EPIC: Effect of Povidone Iodine Periurethral Cleansing on Level of Contamination With Clean Catch

A NA study of Urine Contamination, sponsored by Travis Callahan.

Completed
Registry status
NA
Development phase
20
Enrollment target
1
Study location

NCT03933436: Completed NA study of Urine Contamination, sponsored by Travis Callahan.

NCT03933436 is a NA study of Urine Contamination that has completed, run by Travis Callahan. The registered enrollment target is 20 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03933436, a NA study of Urine Contamination, has completed, sponsored by Travis Callahan.

COMPLETED
Registry status
NA
Development phase
20 participants
Enrollment target
1
Study location

Study Summary

The primary aim of this study is to see if the use of an antiseptic preparation (povidone iodine) versus cold normal saline, will decrease rates of urine contamination during the non-invasive Quick Wee (QW) collection of pediatric urine.

Primary Outcome

Binary yes/no outcome of detection of microbial markers to determine level of contamination

Conditions Studied

Interventions

  • OTHER Iodine swabs.
  • OTHER Saline flush.

Study Locations (1)

Nevada

  • Mike O'Callaghan Military Medical Center - Las Vegas

Trial Details

FieldValue
Enrollment Target 20 participants
Start Date 2019-05-01
Est. Completion 2019-10-28
Phase NA
Travis Callahan

1 total trials

What the finished NCT03933436 record still lists

NCT03933436 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 20 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower).

The record links to 1 condition, with Urine Contamination appearing as the primary indexed condition, and to 2 interventions - of which Iodine swabs. is the first listed.

NCT03933436 reports a single indexed study location in Nevada.

Frequently Asked Questions

What is clinical trial NCT03933436 about?

NCT03933436 is a clinical study titled "EPIC: Effect of Povidone Iodine Periurethral Cleansing on Level of Contamination With Clean Catch". The primary aim of this study is to see if the use of an antiseptic preparation (povidone iodine) versus cold normal saline, will decrease rates of urine contamination during the non-invasive Quick Wee (QW) collection of pediatric urine.

What is the current status of trial NCT03933436?

This trial is currently completed. It is a NA study. The enrollment target is 20 participants. The study started on 2019-05-01. Estimated completion is 2019-10-28.

What conditions does trial NCT03933436 study?

This clinical trial studies the following conditions: Urine Contamination.

What interventions are being tested in trial NCT03933436?

The interventions under investigation include: Iodine swabs. (OTHER), Saline flush. (OTHER).

Who is sponsoring clinical trial NCT03933436?

This trial is sponsored by Travis Callahan, which has 1 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT03933436 being conducted?

This trial has 1 study location across Nevada. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

How this trial's enrollment target compares

Where NCT03933436's enrollment target sits among peer trials

20 1768th of 2000 higher than 140 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00573339 · 20 participants

    Cardiac Magnetic Resonance Imaging (MRI) Normal Reference Control Group Testing

  • NCT00692939 · 20 participants · Phase 1

    Autologous Stem Cell Transplantation for Crohn's Disease

  • NCT00967785 · 20 participants · Phase 1

    A Phase I Study of Mozobil in the Treatment of Patients With WHIMS

  • NCT01406691 · 20 participants · Phase 4

    Light Flashes to Treat Delayed Sleep Phase Disorder (DSPD)

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT03933436, the US trial registry maintained by the National Library of Medicine. NCT03933436 (small enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.